CA Stock MarketDetailed Quotes

CTX Crescita Therapeutics Inc

Watchlist
  • 0.660
  • -0.010-1.49%
15min DelayMarket Closed Aug 30 16:00 ET
12.79MMarket Cap-4400P/E (TTM)

Crescita Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-11.87%9.01M
-7.24%9.53M
13.92%9.39M
13.92%9.39M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-27.30%8.24M
-12.24%10.74M
-Cash and cash equivalents
-11.87%9.01M
-7.24%9.53M
13.92%9.39M
13.92%9.39M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-27.30%8.24M
-12.24%10.74M
-Accounts receivable
-40.36%2.19M
-17.70%3.45M
-73.91%1.19M
-73.91%1.19M
-34.79%2.32M
2.63%3.67M
20.71%4.2M
116.47%4.56M
116.47%4.56M
242.73%3.56M
Total current assets
-13.11%17.04M
-9.97%18.37M
-9.89%18.49M
-9.89%18.49M
-6.16%18.81M
-0.63%19.61M
-2.23%20.41M
2.11%20.52M
2.11%20.52M
5.43%20.05M
Non current assets
-Accumulated depreciation
----
----
-9.48%-2.61M
-9.48%-2.61M
----
----
----
-9.66%-2.39M
-9.66%-2.39M
----
-Long term equity investment
-41.14%588K
-36.41%702K
-32.53%815K
-32.53%815K
-28.01%892K
-25.17%999K
-22.80%1.1M
-20.79%1.21M
-20.79%1.21M
-23.42%1.24M
Non current note receivables
----
----
--0
--0
--196K
--196K
--289K
--455K
--455K
----
-Goodwill
-16.30%2.03M
-32.97%1.78M
-30.46%1.99M
-30.46%1.99M
-28.33%2.21M
-26.46%2.43M
-24.82%2.65M
-23.37%2.87M
-23.37%2.87M
-22.06%3.09M
Regulatory assets
-39.16%2.3M
-17.47%3.51M
-55.52%2.78M
-55.52%2.78M
-33.41%2.48M
2.72%3.78M
20.38%4.25M
66.51%6.24M
66.51%6.24M
172.59%3.73M
Non current deferred assets
-6.31%1.43M
-7.63%1.45M
-5.86%1.48M
-5.86%1.48M
2.05%1.49M
0.73%1.52M
-0.19%1.57M
-5.65%1.57M
-5.65%1.57M
-16.14%1.46M
Total assets
----
----
-79.21%21K
-79.21%21K
----
----
----
-30.34%101K
-30.34%101K
----
Liabilities
Current liabilities
Current debt and capital lease obligation
8.21%448K
8.29%444K
8.40%439K
8.40%439K
10.29%418K
10.40%414K
-69.83%410K
-69.84%405K
-69.84%405K
-71.46%379K
-Current capital lease obligation
8.21%448K
8.29%444K
8.40%439K
8.40%439K
10.29%418K
10.40%414K
10.51%410K
10.35%405K
10.35%405K
4.41%379K
-Total tax payable
-38.71%695K
-34.79%804K
-31.48%912K
-31.48%912K
-26.53%1.03M
-24.15%1.13M
-22.11%1.23M
-20.39%1.33M
-20.39%1.33M
-21.71%1.41M
Current liabilities
5.37%5.06M
-11.08%5.12M
-19.70%4.86M
-19.70%4.86M
-17.48%5.22M
-24.58%4.8M
-26.24%5.76M
-9.93%6.06M
-9.93%6.06M
-5.83%6.33M
Non current liabilities
-Long term debt
-41.14%588K
-36.41%702K
-32.53%815K
-32.53%815K
-28.01%892K
-25.17%999K
-22.80%1.1M
-20.79%1.21M
-20.79%1.21M
-23.42%1.24M
Non current accrued expenses
-16.99%1.66M
-21.94%1.68M
-20.02%1.85M
-20.02%1.85M
-21.02%1.86M
-20.26%2M
-17.21%2.15M
-10.40%2.31M
-10.40%2.31M
-4.76%2.36M
Total non current liabilities
-3.05%5.76M
-15.26%5.93M
-21.82%5.78M
-21.82%5.78M
-19.12%6.26M
-24.50%5.94M
-25.55%6.99M
-12.02%7.39M
-12.02%7.39M
-9.18%7.74M
Shareholders'equity
Share capital
-4.81%53.6M
-4.29%53.89M
-3.49%54.34M
-3.49%54.34M
-2.23%55.35M
-1.88%56.3M
-2.53%56.3M
-3.06%56.3M
-3.06%56.3M
-2.93%56.61M
-common stock
-4.81%53.6M
-4.29%53.89M
-3.49%54.34M
-3.49%54.34M
-2.23%55.35M
-1.88%56.3M
-2.53%56.3M
-3.06%56.3M
-3.06%56.3M
-2.93%56.61M
Additional paid-in capital
53.37%6.63M
47.92%6.36M
39.45%5.96M
39.45%5.96M
26.95%5.08M
27.95%4.32M
40.81%4.3M
54.24%4.27M
54.24%4.27M
57.04%4M
Gains losses not affecting retained earnings
-0.97%1.12M
-0.88%1.12M
-0.88%1.12M
-0.88%1.12M
-1.65%1.13M
-1.73%1.13M
-1.74%1.13M
-1.22%1.13M
-1.22%1.13M
9.51%1.15M
Other equity interest
66.91%454K
-36.17%270K
----
----
-28.93%420K
-55.56%272K
-33.91%423K
----
----
--591K
Noncontrolling interests
-2.23%351K
-0.29%349K
4.68%358K
4.68%358K
19.48%368K
16.18%359K
7.36%350K
1.18%342K
1.18%342K
-6.67%308K
Total equity
-13.48%22.95M
-13.55%24.07M
-13.64%24.6M
-13.64%24.6M
-8.44%25.37M
-4.55%26.53M
-5.35%27.84M
-1.52%28.48M
-1.52%28.48M
-1.11%27.71M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -11.87%9.01M-7.24%9.53M13.92%9.39M13.92%9.39M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-27.30%8.24M-12.24%10.74M
-Cash and cash equivalents -11.87%9.01M-7.24%9.53M13.92%9.39M13.92%9.39M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-27.30%8.24M-12.24%10.74M
-Accounts receivable -40.36%2.19M-17.70%3.45M-73.91%1.19M-73.91%1.19M-34.79%2.32M2.63%3.67M20.71%4.2M116.47%4.56M116.47%4.56M242.73%3.56M
Total current assets -13.11%17.04M-9.97%18.37M-9.89%18.49M-9.89%18.49M-6.16%18.81M-0.63%19.61M-2.23%20.41M2.11%20.52M2.11%20.52M5.43%20.05M
Non current assets
-Accumulated depreciation ---------9.48%-2.61M-9.48%-2.61M-------------9.66%-2.39M-9.66%-2.39M----
-Long term equity investment -41.14%588K-36.41%702K-32.53%815K-32.53%815K-28.01%892K-25.17%999K-22.80%1.1M-20.79%1.21M-20.79%1.21M-23.42%1.24M
Non current note receivables ----------0--0--196K--196K--289K--455K--455K----
-Goodwill -16.30%2.03M-32.97%1.78M-30.46%1.99M-30.46%1.99M-28.33%2.21M-26.46%2.43M-24.82%2.65M-23.37%2.87M-23.37%2.87M-22.06%3.09M
Regulatory assets -39.16%2.3M-17.47%3.51M-55.52%2.78M-55.52%2.78M-33.41%2.48M2.72%3.78M20.38%4.25M66.51%6.24M66.51%6.24M172.59%3.73M
Non current deferred assets -6.31%1.43M-7.63%1.45M-5.86%1.48M-5.86%1.48M2.05%1.49M0.73%1.52M-0.19%1.57M-5.65%1.57M-5.65%1.57M-16.14%1.46M
Total assets ---------79.21%21K-79.21%21K-------------30.34%101K-30.34%101K----
Liabilities
Current liabilities
Current debt and capital lease obligation 8.21%448K8.29%444K8.40%439K8.40%439K10.29%418K10.40%414K-69.83%410K-69.84%405K-69.84%405K-71.46%379K
-Current capital lease obligation 8.21%448K8.29%444K8.40%439K8.40%439K10.29%418K10.40%414K10.51%410K10.35%405K10.35%405K4.41%379K
-Total tax payable -38.71%695K-34.79%804K-31.48%912K-31.48%912K-26.53%1.03M-24.15%1.13M-22.11%1.23M-20.39%1.33M-20.39%1.33M-21.71%1.41M
Current liabilities 5.37%5.06M-11.08%5.12M-19.70%4.86M-19.70%4.86M-17.48%5.22M-24.58%4.8M-26.24%5.76M-9.93%6.06M-9.93%6.06M-5.83%6.33M
Non current liabilities
-Long term debt -41.14%588K-36.41%702K-32.53%815K-32.53%815K-28.01%892K-25.17%999K-22.80%1.1M-20.79%1.21M-20.79%1.21M-23.42%1.24M
Non current accrued expenses -16.99%1.66M-21.94%1.68M-20.02%1.85M-20.02%1.85M-21.02%1.86M-20.26%2M-17.21%2.15M-10.40%2.31M-10.40%2.31M-4.76%2.36M
Total non current liabilities -3.05%5.76M-15.26%5.93M-21.82%5.78M-21.82%5.78M-19.12%6.26M-24.50%5.94M-25.55%6.99M-12.02%7.39M-12.02%7.39M-9.18%7.74M
Shareholders'equity
Share capital -4.81%53.6M-4.29%53.89M-3.49%54.34M-3.49%54.34M-2.23%55.35M-1.88%56.3M-2.53%56.3M-3.06%56.3M-3.06%56.3M-2.93%56.61M
-common stock -4.81%53.6M-4.29%53.89M-3.49%54.34M-3.49%54.34M-2.23%55.35M-1.88%56.3M-2.53%56.3M-3.06%56.3M-3.06%56.3M-2.93%56.61M
Additional paid-in capital 53.37%6.63M47.92%6.36M39.45%5.96M39.45%5.96M26.95%5.08M27.95%4.32M40.81%4.3M54.24%4.27M54.24%4.27M57.04%4M
Gains losses not affecting retained earnings -0.97%1.12M-0.88%1.12M-0.88%1.12M-0.88%1.12M-1.65%1.13M-1.73%1.13M-1.74%1.13M-1.22%1.13M-1.22%1.13M9.51%1.15M
Other equity interest 66.91%454K-36.17%270K---------28.93%420K-55.56%272K-33.91%423K----------591K
Noncontrolling interests -2.23%351K-0.29%349K4.68%358K4.68%358K19.48%368K16.18%359K7.36%350K1.18%342K1.18%342K-6.67%308K
Total equity -13.48%22.95M-13.55%24.07M-13.64%24.6M-13.64%24.6M-8.44%25.37M-4.55%26.53M-5.35%27.84M-1.52%28.48M-1.52%28.48M-1.11%27.71M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg